Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative.

UNLABELLED Barriers to recovering the excess treatment costs associated with health research from local organisations in the United Kingdom can increase research costs, delay completion of high- quality studies and risk disenfranchising health trusts and patients from participation. The authors demonstrate how the process for recovering excess treatment… CONTINUE READING